Thus, more specific studies in obese individuals with insulin resistance will be necessary to confirm these findings using transcriptomic tools to put in context the physiological/clinical role of PPAR-γ2–IGFBP-2 interaction. This evidence concerns the gene PPARG and Insulin resistance.